IDP.L Regulatory News (IDP)

This announcement must not be sent or transmitted, directly or indirectly, into the United States, Australia, Canada or Japan and is not for distribution, directly or indirectly in the United States, Australia, Canada or Japan or any other jurisdiction where the extension or availability of the fundraising (and any other transaction contemplated thereby) would (i) result in a requirement to comply with any governmental or other consent or any registration filing or other formality which InnovaDerma regards as unduly onerous, or (ii) otherwise breach any applicable law or regulation.

InnovaDerma PLC

("InnovaDerma" or the "Company")

Completion of Placing

InnovaDerma (LON: IDP), a UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, announced on 25 November 2016 that it had raised £539,999.60 before expenses, through the placing by Hybridan LLP of 771,428 new ordinary shares of €0.10 each in the capital of the Company (the "Placing Shares") at a placing price of 70 pence per share with new institutional shareholders.

Application has been made for the Placing Shares to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected Admission will become effective and that unconditional dealings will commence on the London Stock Exchange at 8.00 a.m. on 9 December 2016. The Placing Shares will rank pari passu with the existing ordinary shares of the Company. Following Admission, the Company will have 11,116,963 ordinary shares in issue. This figure (11,116,693), is the number which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interests in, the Company under the FCA's Disclosure and Transparency Rules.

Use of Proceeds

The net proceeds of the fundraising will provide the Company with working capital to fund growth into European and US markets and improve supply chain management to meet growing demand for Skinny Tan, a premium self-tanner brand that contains a natural tanning active, to tan and reduce the visible appearance of cellulite.*

*Based on Skinny Tan Consumer research trial results.

Broker Warrants

In connection with the Placing, the Company has agreed to issue warrants to Hybridan LLP to subscribe for up to 42,429 ordinary shares in the capital of the Company ("Broker Warrants").

The Broker Warrants are exercisable in the period from (but excluding) 29 July 2016 to (and including) 29 July 2019, at an exercise price of £0.84 per share.

Further enquiries:

About InnovaDerma:

InnovaDerma PLC (LSE: IDP) specialises in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the UK, US, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

www.innovaderma.com